Innovative Product Launches Ascensia Diabetes Care is actively expanding its product portfolio with advanced continuous glucose monitoring systems like Eversense 365 and E3, offering long-term, minimally disruptive monitoring solutions that can appeal to healthcare providers and patients seeking reliable, innovative diabetes management tools.

Market Expansion & Awareness The company has recently launched marketing campaigns and partnered with pharmacies and healthtech firms to increase market awareness and adoption of its CGM systems, creating opportunities to engage with healthcare professionals and retail chains to expand distribution channels.

Strategic Leadership With recent high-level appointments such as the new CEO, Ascensia is positioning itself for strategic growth and innovation, opening doors for sales collaborations with key decision-makers in the healthcare and medical device sectors.

Focus on Patient Engagement Recognition as a Great Place To Work and partnerships with healthtech companies indicate a strong commitment to employee and partner engagement, which can translate into enhanced customer service and loyalty initiatives that sales teams can leverage for client retention and upselling.

Global Market Presence Operating in multiple regions with a large employee base and a revenue approaching one billion dollars, Ascensia offers significant opportunities to tap into international markets, especially in regions where diabetes management solutions are highly sought after owing to rising prevalence.